General Burden of Adult Atopic Dermatitis: An Observational Study of Disease Perceptions among Patients and Dermatologists in France
Keywords:atopic dermatitis, topical corticosteroids, dermatologist, patient assessment, disease impact
It is important to understand patients’ and dermatologists’ perceptions of various aspects of atopic dermatitis, but there is a lack of studies on quality of life and stakeholder viewpoints in this therapy area. The aim of this study was to compare patients’ and dermatologists’ viewpoints regarding the impact of atopic dermatitis that is uncontrolled by topical corticosteroids. Data were collected from 348 adult patients who responded to self-administered questionnaires, and 150 telephone interviews with the dermatologists who selected them. Patients and dermatologists reported both convergent and divergent assessments of the impact of atopic dermatitis and its treatment. Notable areas of agreement were regarding the safety of emollients, the time required and difficulty of applying topical corticosteroids, especially to certain parts of the body. Divergent views involved the perceived efficacy of available treatments and the impact of atopic dermatitis on professional life. A greater understanding of these differences would help dermatologists to optimize patient care.
Richard MA, Corgibet F, Beylot-Barry M, Barbaud A, Bodemer C, Chaussade V, et al. Sex- and age-adjusted prevalence estimates of five chronic inflammatory skin diseases in France: results of the "OBJECTIFS PEAU" study. J Eur Acad Dermatol Venereol 2018; 32: 1967-1971.
Barbarot S, Auziere S, Dadkari A, Girolomoni G, Puig L, Simpson EL. Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy 2018; 73: 1284-1293.
Drucker AM. Atopic dermatitis: burden of illness, quality of life, and associated complications. Allergy Asthma Proc 2017; 38: 3-8.
Drucker AM, Wang AR, Li W-Q, Sevetson E, Block JK, Qureshi AA. The burden of atopic dermatitis: summary of a report for the National Eczema Association. J Invest Dermatol 2017; 137: 26-30.
Adamson AS. The economics burden of atopic dermatitis. Adv Exp Med Biol 2017; 1027: 79-92.
Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, et al. Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults. Br J Dermatol 2019; 181: 554-565.
Patel KR, Immaneni S, Singam V, Rastogi S, Silverberg JI Association between atopic dermatitis, depression, and suicidal ideation: a systematic review and meta-analysis, J Am Acad Dermatol 2019; 80: 402-410.
Eckert L, Gupta S, Gadkari A, Mahajan P, Gelfand JM. Burden of illness in adults with atopic dermatitis (AD): analysis of National Health and Wellness Survey data from France, Germany, Italy, Spain and the UK. J Am Acad Dermatol 2019; 81: 187-195.
Bender BG, Ballard R, Canono B, Murphy JR, Leung DYM. Disease severity, scratching, and sleep quality in patients with atopic dermatitis. J Am Acad Dermatol 2008; 58: 415-420.
Arents BWM, Mensing U, Seitz IA, Wettemann, Fink-Wagner AH, de Carlo G, Zink A, et al, Atopic eczema score of emotional consequences - a questionnaire to assess emotional consequences of atopic eczema, Allergo J Int 2019; 28: 277-288.
Reed B, Blaiss MS. The burden of atopic dermatitis. Allergy Asthma Proc 2018; 39: 406-410.
Ring J, Zink A, Arents BWM, Seitz IA, Mensing U, Schielein MC, Wettemann N, et al. Atopic eczema: burden of disease and individual suffering - results from a large EU study in adults, J Eur Acad Dermatol Venereol 2019; 33: 1331-1340.
Garmhausen D, Hagemann T, Bieber T, Dimitriou I, Fimmers R, Diepgen T, Novak N. Characterization of different courses of atopic dermatitis in adolescent and adult patients. Allergy 2013; 68: 498-506.
Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab 2015; 66: 8-16.
Deleanu D, Nedelea I. Biological therapies for atopic dermatitis: an update. Exp Ther Med 2019; 17: 1061-1067.
Misery L, Seneschal J, Reguiai Z, Reguiai Z, Merhand S, Héas S, et al. Patient burden is associated with alterations in quality of life in adult patients with atopic dermatitis: results from the ECLA Study. Acta Derm Venereol 2018; 98: 713-714.
Misery L, Seneschal J, Reguiai Z, Merhand S, Héas S, Huet F, et al. The impact of atopic dermatitis on sexual health. J Eur Acad Dermatol Venereol 2019; 33: 428-432.
Langenbruch A, Radtke MA, Gutknecht M, Augustin M. Does the Dermatology Life Quality Index (DLQI) underestimate the disease-specific burden of psoriasis patients? J Eur Acad Dermatol Venereol 2019; 33: 123-127.
How to Cite
Copyright (c) 2021 Angèle Soria, Claire Thénié, Christina Bienenfeld, Delphine Staumont-Sallé
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.